At the Advanced Molecular Diagnostics research lab, we are dedicated to redefining molecular diagnostics for children with various conditions through cutting-edge research in liquid biopsy technologies. Liquid biopsy, a simple blood test utilizing circulating biomarkers, offers a glimpse into the intricate molecular signatures of cancers, vascular malformations, and even neurological conditions like epilepsy. Through our research, we strive to identify robust non-invasive molecular biomarkers specific to these entities, enabling early diagnosis and monitoring of treatment responses for cancers, and matching targeted treatments to vascular malformations and epilepsy. By harnessing the power of these dynamic markers found in blood (and other bodily fluids), we aim to improve outcomes and quality of life for young patients by tailoring therapeutic interventions based on real-time, liquid biopsy-driven information.

Our multidisciplinary team of scientists and clinicians actively engages with fellow researchers and healthcare providers to share insights, pool resources, and explore innovative approaches and applications in the realm of liquid biopsy. Our lab is a hub of diverse projects, each aiming to uncover unique aspects of liquid biopsy applications in paediatrics. From refining detection methods to unravelling the genetic intricacies of childhood cancers, vascular malformations, and epilepsy; our work is fuelled by the desire to make a tangible difference and usher in a new era of personalized, precision medicine for the young patients facing these challenges.

We invite you to explore our ongoing projects, meet our team, and stay updated on the latest advancements in paediatric liquid biopsy research. Together, we aspire to enhance the way we diagnose and care for children with various medical challenges.